Pediapharm Inc. (CVE:PDP – Get Free Report) was up 1.7% on Friday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The firm has a fifty day moving average price of C$0.30 and a two-hundred day moving average price of C$0.30. The stock has a market capitalization of C$66.36 million and a P/E ratio of -4.11. The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Further Reading
- Five stocks we like better than Pediapharm
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What is the Dow Jones Industrial Average (DJIA)?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- 3 Monster Growth Stocks to Buy Now
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.